Companies: 10,795·Total market cap: $144.5T
Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGFOTCHealthcare● Active
$10.65
+$0.00(+0.00%)
Market Cap$29616212
P/E Ratio
52W High$10.8
52W Low$4.266
Overview

Devonian Health Group Inc.(DVHGF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · DVHGF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-3.28dvhgf eps ttm · dvhgf earnings per shareEarnings history
PE Ratio (TTM)dvhgf pe ratio ttm · dvhgf price to earningsPE Ratio deep dive
Revenue (TTM)$9.8Mdvhgf revenue ttm · dvhgf annual revenueFull revenue history
Dividend Yield不分红does dvhgf pay dividends · dvhgf dividend yieldDividend history
Shares Outstanding2.5Mdvhgf shares outstanding · dvhgf floatShares outstanding history
Next EarningsJun 25, 2026Est.dvhgf earnings date · dvhgf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$17.0M▼ 4.43% YoY
202320242025
devonian health group inc. revenue · dvhgf revenue 2025
FY 2025Net Income-$4.3M▼ 254.38% YoY
202320242025
devonian health group inc. net income · dvhgf profit 2025
FY 2025EPS$-1.76▼ 253.01% YoY
202320242025
dvhgf eps · devonian health group inc. earnings per share 2025
TTM:Revenue: $9.8MNet Income: -$8.9MEPS: $-3.28View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+149.41%
1Y-1.39%
5Y-56.50%

关于 Devonian Health Group Inc.

CEOAndre Boulet
IPO DateSep 19, 2022
Employees6
CountryCA

Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat con…

what is devonian health group inc. · dvhgf stock overview · devonian health group inc. company profile · who is devonian health group inc. ceo · dvhgf OTC · devonian health group inc. headquarters · devonian health group inc. business segments

关于股票概览与关键数据

Devonian Health Group Inc.(DVHGF)是 Biotechnology 行业的 Healthcare 类公司,于 Sep 19, 2022 在 OTC 上市。截至最近交易日,DVHGF 股价为 $10.65,市值约为 $29.6M。过去12个月累计回报 -1.39%,年初至今回报 +149.41%。

2025 财年 Devonian Health Group Inc. 营收 $17.0M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Devonian Health Group Inc.(DVHGF)股价为 $10.65,在 OTC 上市,52周区间为 $4.27 – $10.80。

DVHGF 最新股价DVHGF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议